Botanix Pharmaceuticals【BOT】銘柄情報

Botanix Pharmaceuticals Limited (BOT) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.021

( - )

買値

0.021

売値

0.022

出来高

7,960,193

0.02 日の範囲 0.0215

0.018 52 週間の範囲 0.35

時価総額

57.421M

前日終値

0.021

始値

0.021

時刻

200000

0.021

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 22,197,703

発行済株式数

2,734,312,800

配当利回り

PER

-0.41

1 株当たり利益 (EPS)

-0.05

歳入

21.92M

純利益

-88.7M

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age a... Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company’s lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in Melbourne, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.botanixpharma.com

本社

Melbourne, Australia

設立

1984

Botanix Pharmaceuticals Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker BOT. The last closing price for Botanix Pharmaceuticals was AUD0.02. Over the last year, Botanix Pharmaceuticals shares have traded in a share price range of AUD 0.018 to AUD 0.35.

Botanix Pharmaceuticals currently has 2,734,312,800 shares in issue. The market capitalisation of Botanix Pharmaceuticals is AUD57.42 million. Botanix Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.41.

Botanix | World First Human Clinical Study Shows Synthetic CBD Formula Eradicates Staphylococcus Aureus

Clinical stage synthetic cannabinoid company Botanix Pharmaceuticals Limited has today published positive data from a world first human clinical...

Botanix Receives Commitments for A$40m in US-Led Institutional Placement & Announces Appointment of Key US Management Executi...

Key highlights Botanix has received firm commitments for a A$40m placement, led by specialist US-based biotech investment funds and leading US...

Caledonia Announces Support for CME/CBOT Merger

SYDNEY, Australia, July 6 /PRNewswire-FirstCall/ -- Caledonia Investments Pty. Ltd., the Sydney based investment group and largest shareholder...

ICE Sends Letter to CBOT Stockholders Urging Them to Reject CME Proposal

Says CME's Supposedly Enhanced Offer Has Been Raised by Less Than the Increase in CBOT's 2007 Earnings Outlook ATLANTA, June 27...

ICE and CBOE Enter Exclusive Agreement Regarding CBOE Exercise Rights as Part of ICE's Proposed Merger With CBOT; Agree In Princ

CBOT Full Members Holding CBOE Exercise Rights Would Receive $500,000 in Value Per Exercise Right ATLANTA, May 30 /PRNewswire-FirstCall/...

CBOT April Total Volume Increases by 7 Percent Over April 2006; Exchange Achieves Record Monthly Agricultural Volume Totals

- Total Exchange Electronic ADV Up 13 Percent Compared With April 2006 CHICAGO, May 1 /PRNewswire-FirstCall/ -- The Chicago Board of Trade...

CBOT Holdings Reports Record Quarterly Earnings and Revenues

-- Achieves Record Quarterly Trading Volume CHICAGO, April 19 /PRNewswire-FirstCall/ -- CBOT Holdings, Inc. (CBOT), holding company for the...

CBOT Files Brief Challenging CBOE'S Unilateral Attempt to Terminate Exercise Right

CBOT also files letter with the SEC opposing CBOE's attempt to circumvent state court in contract dispute CHICAGO, March 1...

CBOT(R) To Launch 30-Year Swap Futures Contracts

CHICAGO, Feb. 12 /PRNewswire-FirstCall/ -- The Chicago Board of Trade (CBOT(R)) today announced plans to launch a new 30-year Interest Rate Swap...

CBOT January Average Daily Volume up 14 Percent Over January 2006

--Total Exchange Electronic ADV up 22 Percent Compared With January 2006 CHICAGO, Feb. 1 /PRNewswire-FirstCall/ -- The Chicago Board of Trade...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.002	10.5263157895	0.019	0.023	0.018	19742778	0.01997736	DE
4	-0.001	-4.54545454545	0.022	0.025	0.018	14718586	0.02063134	DE
12	-0.019	-47.5	0.04	0.044	0.018	21756521	0.0287158	DE
26	-0.109	-83.8461538462	0.13	0.15	0.018	17365691	0.04306461	DE
52	-0.294	-93.3333333333	0.315	0.35	0.018	13731690	0.08347902	DE
156	-0.109	-83.8461538462	0.13	0.535	0.018	8443384	0.19504043	DE
260	-0.071	-77.1739130435	0.092	0.535	0.018	5635954	0.18419357	DE